The amending protocol of Social Security Agreement (2007) between Czech Republic and United States has been entered into force on 1st May 2016, which was signed on 23rd September 2013 and this protocol generally applies from 1st May 2016.
Related Posts
Italy: Tax Court of Appeals grants US company lower tax rate on dividends in ruling
The Italian Tax Court of Appeals of Abruzzo delivered a decision on 17 February 2026 (Decision 93/2026), allowing a US corporation to benefit from a reduced 1.2% withholding tax rate on dividends received from its Italian subsidiary. Case
Read MoreUS finalises rules identifying tip-receiving occupations under the One, Big, Beautiful Bill
The US Department of the Treasury and the Internal Revenue Service announced on 10 April 2026 that it issued final regulations on the “No Tax on Tips” provision. The One, Big, Beautiful Bill final regulations provide the list of occupations that
Read MoreUS consults proposed regulations on new remittance transfer tax under One, Big, Beautiful Bill
The US Department of the Treasury and the Internal Revenue Service announced, on 10 April 206, that it has proposed regulations that would provide rules and definitions related to the new excise tax imposed on certain remittance transfers, also
Read MoreCroatia, US conclude negotiations on amending protocol to tax treaty
Following its meeting on 9 April 2026, the Croatian government issued a report announcing the conclusion of negotiations for amending protocol to the income tax treaty with the US. It must now go through a process of formal signing and
Read MoreUS Trade Court questions Trump’s legal authority for 10% global tariffs
A US federal trade court panel has raised serious doubts about the legality of President Donald Trump's 10% tariff on most imports, questioning whether the country's trade deficit alone justifies such sweeping duties. During a hearing on Friday,
Read MoreUS imposes 100% tariff on imported branded pharmaceuticals, lower rates for EU, UK, Japan and Korea (Rep.)
US President Donald Trump has signed an executive order imposing sweeping tariffs on imported patented pharmaceuticals, with rates reaching 100% for most products not manufactured domestically. The measure, formalised through a proclamation issued
Read More